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Objectives: The application of hyaluronic acid (HA) in dental treatments is relatively new, and modified-HA
products can be vastly different from each other. This study aims to provide a basis for bridging specific char-
acteristics of HA with its potential applications in dental treatments, evaluating and comparing different types of
HA products and for future research on HA applications in dentistry.
Data sources: Information from the existing literature on HA applications has been cited.
Study selection: Furthermore, this study is specifically oriented to provide oral health care providers with a sci-
entific basis for HA use along with the clinical aspects of HA.
Conclusions: Outcomes from existing and future studies cannot be generalised for HA use in dental applications.
Therefore, we have proposed a scheme to bridge HA specific characteristics to its applications in dental treatments
and compare different HA products used for the same clinical application to identify the most suitable one.
Clinical significance: Highlighting the use of HA in dental treatments and providing a basis for developing new
methods, protocols, and products specifically oriented for dentistry.1. Introduction
Hyaluronic Acid (HA) is a special type of glycosaminoglycan (poly-
saccharide, carbohydrate) and an interesting biomolecule. It has been
used in many medical applications, including cosmetics, aesthetic treat-
ments, and treatment of interstitial cystitis, urinary incontinence, ves-
icoureteral reflux, and osteoarthritis. Studying the essential molecules of
living organisms (including HA) includes knowledge of their sources in
nature and methods of synthesis within an organism or artificial syn-
thesis, the study of their chemical and physical structures, biochemical
reactions, cellular pathways and interactions, and their association with
the organism's developmental stages, nutrition, anatomy, and physi-
ology. Furthermore, it includes the study of their influence on genetics,
health, diseases states, gender, and age, and how they are affected by
environmental factors. Finally, the same biological molecule can be
compared between different organisms (species). It is worth mentioning
that biophysics provides the knowledge of the biomechanics of mole-
cules, tissues, and organs, and how these systems work within an
organism.hateeb).
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focused on the possible applications of HA as a biomolecule along with
proposing a scheme to bridge its specific characteristics to its applications
in dental treatments and to compare different HA products to identify the
most suitable one for particular procedures.
2. Discussion
2.1. Structure and functions of biomolecules
An important characteristic of biomolecules is that they can exist in
multiple conformational forms, mainly due to the different types of bonds
between their individual elements. For instance, glycogen, starch, and
cellulose are all made of glucose units linked by 1–4 glycosidic bonds. In
glycogen and starch, the link is at the alpha position, but in cellulose, it is
at the beta position. The bond configuration affects the geometry of the
molecule resulting in a banded helix for glycogen and starch, so that it
occupies minimal volume in the cell as they are intended for energy
storage, whereas cellulose forms an extended shape as it is intended toarch 2020
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say that ‘a specific structure is proof of a specific function, whereas a
specific function requires a specific structure’ [2].The extra cellular
matrix (ECM) is composed of many biomolecules and proteins, all
composing a sophisticated network. ECM composition and organisation
are tissue-specific and correspond to specific physiological and
biochemical functional properties. Naturally, this specificity tends to be
expressed as the specific rate of synthesis and degradation in different
tissue types and species. For instance, in humans, the HA half-life in the
joints, epidermis, and blood is 1–30 weeks, 1–2 days and 2–5 min,
respectively [2, 3]. The difference in HA half-life in ECM of different
tissues is due to its different conformational forms owing to association
with different biological molecules. The ECM stands for the framework
where cells can attach themselves and perform their physiological
functions [4].2.2. Importance of HA in human body
HA (C14H21NO11) n is a homogenous unbranched glycosaminoglycan
composed of repeated disaccharides. In the human body, HA
biopolymer (native HA) constitutes a major component of the extra-
cellular matrix (ECM), and can be found in many different tissues [2, 5].
Native HA, as a biomolecule, is present in oral tissues, such as the
gingiva and the periodontal ligaments (synthesised by fibroblasts and
keratinocytes), and in low quantities in cementum and the alveolar bone
(synthesised by cementoblasts and osteoblasts). Furthermore, HA is
present in the saliva with a concentration in the range of 148–1270 ng
per milligram of protein in the unstimulated whole saliva [2, 6]. This
variation in HA levels is mainly due to variations in the individual diet,
oral hygiene, genetics, oral anatomy, health and disease state, and
others.
Different concentrations and molecular weights of HA (tissue
dependent) triggers different cell responses. In general, high-molecular-
weight HA (>5 Million Da) has an anti-angiogenic and immunosup-
pressive effects. Medium-size HA (2  104–1 Million Da) is associated
with certain biological processes such as embryogenesis, wound healing
and regeneration. Small-size HA (6  103 Da–2 x 104 Da) is associated
with different cellular processes (e.g. pro-inflammatory, angiogenesis
and gene expression). Small strands of HA can act as inducers of the heat
shock proteins and an anti-apoptotic agent [7].
HA is naturally synthesised by the proteins (HA synthases), which are
of several types in human: HAS1, HAS2, and HAS3 [6,8]. In the human
body, the hyaluronidase enzymes, which are also of several types, are
responsible for enzymatic degradation of HA. It is estimated that 85% of
the HA is turned over in the lymph nodes, and the rest is removed by the
liver and kidneys [9, 10]. Complete HA degradation yields CO2, NH3,
acetate, and lactate, which are further metabolised by hepatocytes to
CO2, H2O, and urea. Native HA molecule along with its receptors, HA
synthases, and HA hyaluronidases, are all tissue-specific and dependent
on the developmental phase, gender, age, health/disease state, and
environmental factors [9, 11, 12, 13].2.3. Natural sources of HA
HA can be obtained either by extraction from animal tissues (usually
rooster combs) or from certain bacterial strains which naturally produce
HA (mainly Streptococcus zooepidemicus) or that have been genetically
modified to (e.g. Bacillus, Agrobacterium, Escherichia coli, and Lactococcus)
produce HA [14]. The process of HA extraction includes the associated
risk of having sources of contamination, such as viruses and animal
proteins (HA extracted from animal sources), and toxins along with
bacterial proteins (HA extracted from bacteria). Such sources of
contamination may trigger an immune response. As per recent reports,
marine organisms are a possible resource for HA [7, 15, 16].2
2.4. Modification of native HA
Although, due to extraction methods used, the conformation of the
extracted HA may be different from that of the native HA in vivo, it is the
closest form to native HA and can be used for certain medical applica-
tions, where such forms of HA are often degraded quickly by hyaluron-
idases. For some medical applications, the extracted HA must be
chemically modified to serve certain cellular or physiochemical proper-
ties. A good example is the chemical modification of HA used in intra-
articular injections, where the residence time (product-dependent)
extends from weeks up to a year after administration of HA into the
articular joint.
Generally, the purpose of HA modification is as follows:
 To enhance its resistance to degradation, and thereby enhancing its
residence time and the duration of its effects [17].
 To adjust some of its properties, such as viscosity, elasticity and hy-
drophilicity, to meet certain physiochemical and mechanical prop-
erties [18].
 To have the HA in the final form of a gel or hard textured scaffold with
specific pore and particle sizes for specific cellular functions (such as
cell adherence or migration) [19].
 To create HA-drug conjugates and micelles for sustained or targeted
drug release [20, 21].
 To link HA to natural or synthetic compounds (e.g. proteins, natural
polymers, liposomes, synthetic polymers, drugs, and so on.) to ach-
ieve certain physiochemical or therapeutic properties [22].
There is a wide array of technical and chemical methods used to
modify HA, each resulting in specific geometry having certain confor-
mational form and physiochemical characteristics. Those physiochemical
characteristics are affected by many factors, including the source of HA,
manufacturing technique, HA molecular weight distribution, modifica-
tion method, chemical agents used during the manufacturing process,
purity of HA, and mixing the HA with other materials (if applied). This
cumulatively affects the method of administration, degradation, resi-
dence time, and possibly the route of elimination of the product.
Accordingly, a biocompatibility profile (including purity, toxicity, im-
purities, etc.) should be established for a modified HA. A famous method
is the cross-linking process, in which the HA chains are joined through
chemical covalent bonds. Cross-linking processes lead to the formation of
3-dimensional (3D) HA networks having modified physiochemical
properties, particularly resistance to degradation, which results in a
prolonged life span in the treated tissue [23].
Review of the available literature for HA use in dental applications
revealed controversial and contradictory outcomes and variable data due
to the large variety of molecular weights, methods of modification, and
HA concentrations reported by previous studies [24]. Therefore, the
outcomes from existing literature cannot be generalised for HA use in
dental applications. In fact, a recently published systematic review [25]
concluded that further well-designed randomised clinical trials will be
needed to evaluate HA use in various clinical scenarios. As the exact
biological functions of HA are still not well understood, there is a ne-
cessity to develop new methods to identify its structure in living tissues,
interactions with other molecules and receptors and to better understand
its association with cellular functions [2].
From clinical aspect, future studies should seek to compare different
HA formulations used for the same clinical application to identify the
most suitable one. To our knowledge, only two published studies have
tested different HA preparations for dental applications. The first study
(Vandana and Singh, 2019) [26] tested the effect of different HA con-
centrations on interdental papillary deficiency treatment and the second
study (Asparuhova et al., 2018) [27] tested two different HA prepara-
tions on primary human oral fibroblasts.
Researchers should make all efforts to study, test, and report HA
characteristics and modifications to enable other researchers compare
Figure 1. Chemical structure of HA showing the chemical groups that can be modified.
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to study and report the microscopical appearance (transmission electron
microscopy for its supramolecular organisation and scanning electron
microscopy for its surface topography, fibrillar organization, and
porosity) and its UV absorption spectra [2].
From the chemical standpoint, there are three chemical groups on the
HA chain that can be modified: the carboxylic acid group (COOH), hy-
droxyl group (OH), and the N-acetyl group (CH3CO) which is located on
the acetamido group (C2H4NO) [23]. Note that the N-acetyl group con-
tains a methyl (CH3) and carbonyl (C¼O) group. Figure 1 shows a dia-
gram of HA and its chemical groups that can be modified.
Depending on method(s) of modification, the applications of HA has a
wide spectrum of possibilities, such as in wrinkle treatment, ophthalmic
surgery, drug delivery, wound healing, cartilage, and bone regeneration,
etc. [7]. We should draw attention that the HA elasticity and viscosity
constitute the practical aspect where their behaviour provides expecta-
tion for their performance under physiological conditions, and thus
provide the basis to select an appropriate HA product for the clinical
treatment. Furthermore, the rheological properties of biological fluids
along with the biomechanical properties at the cellular-, tissue- and
organ-levels are important to draw an overall understanding of the
mechanism by which the entire body systemworks and can give excellent
insights for possible treatments and for related materials. Regarding oral
tissues for instance, the elasticity of the dental enamel is in the range of
1030–1646 MPa, whereas it is 1376–1932 MPa for the dental dentin
[28]. At the cellular level, human mesenchymal stem cells can differen-
tiate into neurogenic phenotypes if cultured on a hydrogel with visco-
elasticity similar to that of the brain (0.1–1.0 kPa), but they differentiate
into myogenic phenotypes on hydrogels with viscoelasticity similar to
that of the muscles (8–17 kPa). The stem cells of periodontal ligament,
dental pulp, and apical papilla can differentiate into osteoblasts, chon-
drocytes, or neurocytes depending on the nature of trigger and medium
in vitro. Thus, the different rheological properties of HA-based gels can
trigger different cellular responses [2, 29, 30].
2.5. Considerations for use of biomaterials specific to dentistry
When investigating biomaterials and their medical applications, they
are intended to replace, enhance, adjust, mimic or modify a biological
function using a synthetic (metal, polymer, etc.) or biological material,
either as a standalone material or mixed with other biological, natural or
synthetic one. Broadly speaking, biological materials (including HA)
used in dental applications are mainly intended to regenerate soft tissues,
work as a physical barrier between soft and hard tissues (bone), assist in
wound healing and regenerate hard tissues.3
Dental procedures related to the regeneration (for soft and hard tis-
sue) and wound healing are broadly divided into two groups: 1) surgical
procedures including treatment for sinus lifting, surgical treatment for
periodontitis, bone grafting and regeneration, surgical treatment for
gingival recession, and socket preservation. 2) non-surgical procedures
including treatment for papillae regeneration, non-surgical treatment for
periodontitis, mouth ulcers, and gingivitis [31].
For both, surgical and non-surgical procedures, and in relation to
regeneration and wound healing, four major factors are needed for op-
timum outcomes: 1) viable cells as building blocks, 2) the trigger or
chemical signal to start and stop the cellular processes, 3) angiogenesis to
supply needed nutrients and eliminate cellular waste, and 4) scaffold as a
cast for cells to grow in 3D [32]. With regard to these factors, HA
(modification dependent) can function as a gel scaffold, trigger, or even
as a reservoir for releasing chemical signals (such as hormones or growth
factors). HA as a standalone material does not have enough mechanical
integrity; therefore, the three possible functions (as gel scaffold, trigger,
and reservoir) represent its main applications, as a companion bioma-
terial to dental procedures, particularly those related to regeneration and
wound healing.
Scaffolds (rigid forms and gel forms) should have certain character-
istics to enable the cells to adhere to them and grow, and they should be
biocompatible and biodegradable. For hydrogel scaffolds (including HA
gel scaffolds), their mode of action depends on their physical and bio-
logical characteristics [33, 34].
Growth factors are biological molecules which trigger the cells and
enzymes during biological processes, but they cannot form a 3D material
as they are not structural in their nature. Nevertheless, they can reinforce
the basic 3D scaffold. An appropriately designed HA scaffold can work as
a reservoir for growth factors, thus containing the cellular triggers and
simultaneously releasing the factors over a certain period, depending on
its design and on many factors related to the final form and physi-
ochemical properties of the HA molecule as previously mentioned [35].
Generally, a modified cross-linked HA is often first anti-inflammatory in
function upon its introduction into a tissue. Upon its degradation,
depending on the type and degree of its modification, it may trigger
different cellular functions.
From practical and clinical dental treatment viewpoints, there are
some other factors to consider regarding the use of biological materials
(including HA). Most dental procedures related to regeneration are ex-
pected to give basic outcomes (in relation to regeneration time) within
3–6 months of the treatment, and are procedure dependent; therefore,
similar or earlier result time frames are expected with the use of bio-
logical materials. However, this may not be the case; for instance, if the
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over the treated area what makes its complete isolation impossible.
Accordingly, this factor (possibility of mixing with blood) must be
considered when designing biological materials for oral applications. If
the HA is in the form of a gel scaffold, mixing with blood is considered
beneficial as it will possess an intrinsic reservoir of the biological factors
contained in the blood. Also, the possible effects between saliva and the
biological material should be considered in case of direct contact be-
tween them. Finally, one of the most important factors is the continuous
existence of bacterial communities, which should be considered carefully
upon using biomaterials. Generally, HA have a bacteriostatic effect which
manifests by neutralising bacterial hyaluronate lyase enzymes and is
applicable with dental implants. Designing HA with a bactericidal agent
can be very beneficial for certain clinical cases where high local con-
centration of the bacterial agent over a certain period is required.
Considering HA as a biological material depends on its final form and
characteristics. It can be used as a standalone material to trigger certain
cellular functions, a 3D gel scaffold for cells growth and differentiation,
gel scaffold working as a physical barrier between soft and hard tissue,
gel scaffold containing growth factors or other natural factors (bone
morphogenic factors, fibroblast growth factors, platelet-derived growth
factors) released over certain time and/or concentrations, carrier for
drugs ensuring their sustained release, and co-material with other bio-
logical (fibrin, collagen, chondroitin sulphate, hydroxy apatite), natural
(cellulose, chitin, starch, alginate, silk), or synthetic materials for
enhanced function of either entity. HA applications in dental procedures
vary widely, and one should always keep in mind the four essential
factors (cell viability, type of cellular trigger, angiogenesis, physico-
chemical characteristics of the scaffold) required for regeneration or
wound healing as evaluation tools when exploring the possible applica-
tions or expected outcome results of a natural biomaterial [30, 36].
Some examples on HA uses in dentistry include:
 Injecting HA for papilla regeneration [37].
 Covering the dental implant with HA to enhance its osseointegration.
 Mixing the HA (recommended mixing ratio 1:1) with synthetic bone
grafting material for sinus lifting, socket preservation, and peri-
odontal regeneration procedures for enhanced bone growth, even
distribution, and increased density of the newly formed bone block
[38].
 Covering the surgical area (from inside and outside) by HA to
enhance and to accelerate the tissue healing process (including sur-
gical gingival recession treatment) [39].
 Using HA after scaling and root planning as an adjacent therapy for
periodontitis.
 Topical application of HA for treatment of oral ulcers.
 Using HA as an adjacent to gingivitis and peri-implantitis treatments.
 Using HA as an adjacent to non-surgical gingival recession treatment.
 Mixing HA with platelet-rich fibrin, plasma, and growth factors to
enhance overall outcomes [40].
 Using HA as a nano-sized drug carrier [41].
 Using HA as a matrix to encapsulate stem cells and signalling mole-
cules for reconstruction of temporomandibular joint, salivary glands,
dental pulp, dental bone, enamel, root-canal, and mucosa [42, 43,
44].
Practically, physicians may need to compare between available HA
products to identify differences in terms of their clinical use. Thus, it is
logical to provide a model scheme (Figure 2) summarising the relevant
considerations for evaluation of an HA product, in anticipation of its
possible uses and expected outcomes. This scheme can be used or
modified for use with any biological or natural material with generally
similar characteristics.
It is worth mentioning that the scheme (Figure 2) has been designed
for use by oral care providers as a checklist of different levels depending
on available information. Upon knowledge of exact characteristics of the5
material in use and considering mentioned parameters, it can be bridged
with its possible application in dentistry. At the same time, this scheme
(Figure 2) can be reversely used in designing a product which matches
the desired features of the planned therapy.
3. Conclusion
The biological properties of HA depend onmany parameters, and thus
it is important for oral care providers to be able to compare between
different products. This study provides the scientific background for HA
use and a model scheme as a basis to bridge specific characteristics of HA
with its potential applications in dental treatments. Comparison of the
proposed parameters constitutes a basis for development of new
methods, protocols, and products specifically oriented for dentistry.
Declarations
Author contribution statement
All authors listed have significantly contributed to the development
and the writing of this article.
Funding statement
This research did not receive any specific grant from funding agencies
in the public, commercial, or not-for-profit sectors.
Competing interest statement
The authors declare no conflict of interest.
Additional information
No additional information is available for this paper.
References
[1] R. Stern, M. Jedrzejas, Carbohydrate polymers at the center of life’s origins: the
importance of molecular processivity, Chem. Rev. 108 (2008) 5061–5085.
[2] R. Al-Khateeb, J. Prpic, Hyaluronic acid: the reason for its variety of physiological
and biochemical functional properties, Appl. Clin. Res. Clin. Trials Regul. Aff. 6
(2019) 112–159.
[3] T. Wight, Provisional matrix: a role for versican and hyaluronan, Matrix Biol. 60–61
(2017) 38–56.
[4] T. Pollard, W. Earnshaw, G. Johnson, J. Lippincott-Schwartz, in: Cell Biology, third
ed., Elsevier Inc., Philadelphia, 2017, pp. 505–555.
[5] American Chemical Society, American chemical society, Accessed 5 Jan. 2020,
https://www.acs.org/content/acs/en.html 2020, 2020.
[6] M. Pogrel, M. Lowe, R. Stern, Hyaluronan (hyaluronic acid) in human saliva, Arch.
Oral Biol. 41 (1996) 667–671.
[7] C. Boeriu, J. Springer, F. Kooy, L. van den Broek, G. Eggink, Production methods for
hyaluronan, Int. J. Carbohydr. Chem. 2013 (2013) 1–14.
[8] J. Spicer Lee, A. Hyaluronan, A multifunctional, megaDalton, stealth molecule,
Curr. Opin. Cell Biol. 12 (2000) 581–586.
[9] S. Ghatak, E. Maytin, J. Mack, V. Hascall, I. Atanelishvili, R. Moreno Rodriguez,
R. Markwald, S. Misra, Roles of proteoglycans and glycosaminoglycans in wound
healing and fibrosis, Int. J. Cell Biol. 2015 (2015) 1–20.
[10] J. Fraser, T. Laurent, U. Laurent, Hyaluronan: its nature, distribution, functions and
turnover, J. Intern. Med. 242 (1997) 27–33.
[11] V. Prajapati, P. Maheriya, Hyaluronic acid as potential carrier in biomedical and
drug delivery applications. Functional Polysaccharides for Biomedical Applications,
2019, pp. 213–265.
[12] K. Dicker, L. Gurski, S. Pradhan-Bhatt, R. Witt, M. Farach-Carson, X. Jia,
Hyaluronan: A simple polysaccharide with diverse biological functions, Acta
Biomater. 10 (4) (2014) 1558–1570.
[13] K. J.W, Practical Aspects of Hyaluronan Based Medical Products, CRC/Taylor &
Francis, Boca Raton, 2006, p. 12.
[14] L. Liu, Y. Liu, J. Li, G. Du, J. Chen, Microbial production of hyaluronic acid: current
state, challenges, and perspectives, Microb. Cell Factories 10 (2011) 99.
[15] S. Giji, M. Arumugam, Isolation and characterization of hyaluronic acid from
marine organisms, Adv. Food Nutr. Res. (2014) 61–77.
[16] G. Kogan, L. Soltes, R. Stern, P. Gemeiner, Hyaluronic acid: a natural biopolymer
with a broad range of biomedical and industrial applications, Biotechnol. Lett. 29
(2006) 17–25.
R. Al-Khateeb, I. Olszewska-Czyz Heliyon 6 (2020) e03722[17] J. Patterson, R. Siew, S. Herring, A. Lin, R. Guldberg, P. Stayton, Hyaluronic acid
hydrogels with controlled degradation properties for oriented bone regeneration,
Biomaterials 31 (2010) 6772–6781.
[18] E. Bonnevie, D. Galesso, C. Secchieri, L. Bonassar, Frictional characterization of
injectable hyaluronic acids is more predictive of clinical outcomes than traditional
rheological or viscoelastic characterization, PloS One 14 (2019), e0216702.
[19] J. Kablik, G. Monheit, L. Yu, G. Chang, J. Gershkovich, Comparative physical
properties of hyaluronic acid dermal fillers, Dermatol. Surg. 35 (2009) 302–312.
[20] G. Huang, H. Huang, Application of hyaluronic acid as carriers in drug delivery,
Drug Deliv. 25 (2018) 766–772.
[21] K. Kim, H. Choi, E.S. Choi, M.-H. Park, J.-H. Ryu, Hyaluronic acid-coated
nanomedicine for targeted cancer therapy, Pharmaceutics 11 (2019) 301.
[22] A. Sionkowska, B. Kaczmarek, Preparation and characterization of composites
based on the blends of collagen, chitosan and hyaluronic acid with nano-
hydroxyapatite, Int. J. Biol. Macromol. 102 (2017) 658–666.
[23] C. Schante, G. Zuber, C. Herlin, T. Vandamme, Chemical modifications of
hyaluronic acid for the synthesis of derivatives for a broad range of biomedical
applications, Carbohydr. Polym. 85 (2011) 469–489.
[24] K. Bertl, C. Bruckmann, P. Isberg, B. Klinge, K. Gotfredsen, A. Stavropoulos,
Hyaluronan in non-surgical and surgical periodontal therapy: a systematic review,
J. Clin. Periodontol. 42 (2015) 236–246.
[25] M. Eliezer, J. Imber, A. Sculean, N. Pandis, S. Teich, Hyaluronic acid as adjunctive
to non-surgical and surgical periodontal therapy: a systematic review and meta-
analysis, Clin. Oral Invest. 23 (2019) 3423–3435.
[26] K. Vandana, S. Singh, Use of different concentrations of hyaluronic acid in
interdental papillary deficiency treatment: a clinical study, J. Indian Soc.
Periodontol. 23 (2019) 35.
[27] M. Asparuhova, D. Kiryak, M. Eliezer, D. Mihov, A. Sculean, Activity of two
hyaluronan preparations on primary human oral fibroblasts, J. Periodontal. Res. 54
(2018) 33–45.
[28] K. Chun, H. Choi, J. Lee, Comparison of mechanical property and role between
enamel and dentin in the human teeth, J. Dent. Biomech. 5 (2014).
[29] A. Engler, S. Sen, H. Sweeney, D. Discher, Matrix elasticity directs stem cell lineage
specification, Cell 126 (2006) 677–689.
[30] A. Iranparvar, A. Nozariasbmarz, S. DeGrave, L. Tayebi, Tissue engineering in
periodontal regeneration, Appl. Biomed. Eng. Dentistry (2019) 301–327.
[31] C. Susin, U. Wikesj€o, Regenerative periodontal therapy: 30 years of lessons
learned and unlearned, Periodontol 62 (2013) (2000) 232–242.6
[32] E. Jabbarzadeh, T. Starnes, Y. Khan, T. Jiang, A. Wirtel, M. Deng, Q. Lv, L. Nair,
S. Doty, C. Laurencin, Induction of angiogenesis in tissue-engineered scaffolds
designed for bone repair: a combined gene therapy-cell transplantation approach,
Proc. Natl. Acad. Sci. Unit. States Am. 105 (32) (2008) 11099–11104.
[33] M. Collins, C. Birkinshaw, Hyaluronic acid-based scaffolds for tissue engineering—a
review, Carbohydr. Polym. 92 (2013) 1262–1279.
[34] D. Discher, Tissue cells feel and respond to the stiffness of their substrate, Science
310 (2005) 1139–1143.
[35] S. Vigier, T. Fül€op, Exploring the extracellular matrix to create biomaterials.
Composition and function of the extracellular matrix in the human body, 2016.
[36] E. Ahmadian, S. Dizaj, A. Eftekhari, E. Dalir, P. Vahedi, A. Hasanzadeh, M. Samiei,
The potential applications of hyaluronic acid hydrogels in biomedicine, Drug
Research 70 (1) (2019) 6–11.
[37] F. Awartani, D. Tatakis, Interdental papilla loss: treatment by hyaluronic acid gel
injection: a case series, Clin. Oral Invest. 20 (2015) 1775–1780.
[38] L. Cirligeriu, A. Cimpean, H. Calniceanu, M. Vladau, S. Sarb, M. Raica, L. Nica,
Hyaluronic acid/bone substitute complex implanted on chick embryo
chorioallantoic membrane induces osteoblastic differentiation and angiogenesis,
but not inflammation, Int. J. Mol. Sci. 19 (2018) 4119.
[39] A. Pilloni, P. Schmidlin, P. Sahrmann, A. Sculean, M. Rojas, Effectiveness of
adjunctive hyaluronic acid application in coronally advanced flap in Miller class I
single gingival recession sites: a randomized controlled clinical trial, Clin. Oral
Invest. 23 (2018) 1133–1141.
[40] M. Peck, D. Hiss, L. Stephen, A. Olivier, The in vitro effect of leukocyte- and platelet-
rich fibrin (L-PRF) and cross-linked hyaluronic acid on fibroblast viability and
proliferation, S. Afr. Dent. J. 73 (2018).
[41] A. Turcsanyi, N. Varga, E. Csapo, Chitosan-modified hyaluronic acid-based
nanosized drug carriers, Int. J. Biol. Macromol. 148 (2020) 218–225.
[42] A. Ardeshirylajimi, A. Golchin, J. Vargas, L. Tayebi, Application of stem cell
encapsulated hydrogel in dentistry, Appl. Biomed. Eng. Dentistry (2019) 289–300.
[43] E. Ahmadian, A. Eftekhari, S. Dizaj, S. Sharifi, M. Mokhtarpour, A. Nasibova,
R. Khalilov, M. Samiei, The effect of hyaluronic acid hydrogels on dental pulp stem
cells behavior, Int. J. Biol. Macromol. 140 (2019) 245–254.
[44] S. Lee, J. Ryu, M. Do, E. Namkoong, H. Lee, K. Park, NiCHE platform: nature-
inspired catechol-conjugated hyaluronic acid environment platform for salivary
gland tissue engineering, ACS Appl. Mater. Interfaces 12 (4) (2020) 4285–4294.
